The Risk Reduction of Accidental Exposure-Related Systemic Allergic Reactions Extrapolated Based on Food Challenge Data After 1 Year of Peanut Oral Immunotherapy

Shengsheng Yu, Alex Smith, Steven Hass, Eric Q. Wu, Xinglei Chai, Jenny Zhou, Rajeev Ayyagari, Jun S. Liu, Dan Robison, Sarah M. Donelson, Stephen A. TillesAdvances 2021 · DOI

Abstract

Oral immunotherapy with PTAH is expected to result in a substantially greater reduction in risk of SAR following accidental exposure compared to placebo among children with peanut allergy.
BibTeX
@inproceedings{yu2021risk,
  author = {Shengsheng Yu and Alex Smith and Steven Hass and Eric Q. Wu and Xinglei Chai and Jenny Zhou and Rajeev Ayyagari and Jun S. Liu and Dan Robison and Sarah M. Donelson and Stephen A. Tilles},
  title = {{The Risk Reduction of Accidental Exposure-Related Systemic Allergic Reactions Extrapolated Based on Food Challenge Data After 1 Year of Peanut Oral Immunotherapy}},
  booktitle = {Advances},
  year = {2021},
  doi = {10.1007/s12325-021-01843-2},
}

Loading related content...

Figure